• Ownership

Christopher Yea - Insider Trading & Ownership

Entity
Individual
Location
One Kendall Square, Building 200, Suite 2203, Cambridge, MA
Summary
The estimated net worth of Christopher Yea is at least $1.93M dollars as of February 25, 2025. Christopher Yea is the CHIEF DEVELOPMENT OFFICER of KalVista Pharmaceuticals, Inc. and owns shares of KalVista Pharmaceuticals, Inc. (KALV) stock worth about $1.93M.
All Insider Reports
All Insider Reports

Ownership of Christopher Yea

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KALV KalVista Pharmaceuticals, Inc. Chief Development Officer $1.93M -$376K -16.3% Feb 21, 2025

Insider Transactions Reported by Christopher Yea:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.